Positively Aware Epzicom

Epzicom

abacavir/lamivudine (ABC/3TC)

Recommended as component of initial regimen for most people when used in combination with dolutegravir (as Triumeq)
Nucleoside "Nuke"

Standard Dose

One tablet once daily, without regard to food. Tablet contains 600 mg abacavir and 300 mg lamivudine. Must be taken in combination with another antiretroviral(s) which does not contain the medications in this drug or medication from the same drug class.

Take missed dose as soon as possible, unless it is closer to the time of your next dose. Do not double up on your next dose. Approved for adults and children weighing 55 pounds (25 kg) or more. Not recommended for those with decreased kidney function (creatinine clearance less than 50 mL/min) due to lamivudine component, or those with mild liver impairment due to abacavir component. Alternative doses may be obtained by using the individual components of this medication.

 See the individual drugs contained in Epzicom: Epivir and Ziagen.

 See package insert for more complete information on potential side effects and interactions.

Manufacturer

ViiV Healthcare
viivhealthcare.com
(877) 844-8872
epzicom.com

AWP

$1,550.05/month;
generic: $1,395.05/month


Potential Side Effects and Toxicity

Potential Drug Interactions

More Information

Doctor Comments

Activist Comments